Streetbeat News

Stock Prices

ASAN

Asana projects Q1 adjusted EPS between $(0.09) and $(0.08), slightly below the $(0.08) estimate, with revenues expected to be $168M-$169M, aligning with the $168.25M estimate. For FY25, the adjusted EPS is forecasted to be between $(0.22) and $(0.19), matching the lower end of the $(0.22) estimate, while revenue projections of $716M-$722M fall short of the $724.75M estimate.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:16 pm

DDOG

Datadog's (NYSE:DDOG) short interest has increased by 18.08% since the last report, with 11.77 million shares sold short, representing 4.18% of its float. This indicates a bearish market sentiment, although it's higher than its peer group average of 3.95%. The coverage time for these short positions is approximately 1.81 days.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:15 pm

CVGW

Calavo Growers (NASDAQ:CVGW) reported Q1 earnings with an EPS of $-0.01, missing estimates by -106.0% against an expected $0.17. Revenue decreased to $226.20 million from the previous year. The company's past earnings performance shows a pattern of missing EPS estimates, leading to a 6.0% drop in share price after last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:15 pm

LUNR

Intuitive Machines (NYSE:LUNR) has seen a significant increase in short interest, with 22.29% of its float being shorted, which is above its peer group average of 10.82%. This rise in short interest could indicate a bearish market sentiment towards LUNR, but it's also noted that increasing short interest can sometimes be bullish.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:15 pm

OCUL

Ocular Therapeutix (NASDAQ:OCUL) reported Q4 earnings with a miss on estimated earnings by -17.0%, posting an EPS of $-0.35 against an estimate of $-0.3. Revenue increased by $726 thousand from the same period last year. Despite beating EPS estimates in Q3 2023, the company's share price dropped by 13.0% the following day.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:15 pm

ADIL

Adial Pharmaceuticals (NYSE:ADIL) has seen a significant increase in short interest, with the short percent of float rising 692.2% to 11.17%. This indicates a bearish market sentiment towards ADIL, although it doesn't necessarily predict a near-term price fall. Compared to its peers, ADIL has a higher short interest, suggesting more bearish sentiment than average within its peer group.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:15 pm

BODI

Beachbody Co (NYSE:BODI) reported Q4 earnings with an EPS of $-3.48, missing estimates by -12.0% and experiencing a revenue decline of $29.16 million from the previous year. This follows a pattern of missed EPS estimates in previous quarters, which previously led to a 6.0% drop in share price.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:15 pm

LFMD

LifeMD (NASDAQ:LFMD) reported Q4 earnings with an EPS of $0.15, significantly beating the estimated -$0.14 and marking a substantial 206.99% beat. Revenue increased by $16.74 million from the same period last year. Despite past earnings beats, such as the Q3 2023 beat by $0.23, LifeMD's share price dropped by 5.0% the following day. The company has consistently outperformed EPS estimates over the past four quarters.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:15 pm

LFMD

LifeMD (NASDAQ:LFMD) reported Q4 2023 adjusted EPS of $0.15, surpassing the $(0.14) estimate, with sales of $44.860M beating the $40.494M estimate, a 59.53% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:14 pm

MTN

Vail Resorts' stock price declined following the announcement of disappointing Q2 financial results and a reduction in fiscal 2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:13 pm